The IPO of Wuxi AppTec Group on the Shanghai Stock Exchange in May was a milestone event in 2018, revealing the success of a CRO company in the pharmaceutical industry in China. Commensurate with this, its sister company WuXi Biologics, focusing on biologics research, was listed on the Hong Kong stock market. It commits to be an open access biologics technology platform. Miles Yao of Marketvisor AgConsulting Inc. discusses what it takes to be successful in the animal health sector.